A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia
Name:
Br J Haematol - 2022 - Coats - ...
Size:
660.0Kb
Format:
PDF
Description:
From UNPAYWALL
Authors
Coats, T.Bean, D.
Basset, A.
Sirkis, T.
Brammeld, J.
Johnson, S.
Thomas, I.
Gilkes, A.
Raj, K.
Dennis, M.
Knapper, S.
Mehta, P.
Khwaja, A.
Hunter, H.
Tauro, S.
Bowen, D.
Jones, G.
Dobson, R.
Russell, N.
Dillon, R.
Affiliation
Haematology Department, Royal Devon & Exeter NHS Foundation Trust, Exeter, UKIssue Date
2021
Metadata
Show full item recordAbstract
Induction therapy for acute myeloid leukaemia (AML) has changed with the approval of a number of new agents. Clinical guidelines can struggle to keep pace with an evolving treatment and evidence landscape and therefore identifying the most appropriate front-line treatment is challenging for clinicians. Here, we combined drug eligibility criteria and genetic risk stratification into a digital format, allowing the full range of possible treatment eligibility scenarios to be defined. Using exemplar cases representing each of the 22 identified scenarios, we sought to generate consensus on treatment choice from a panel of nine aUK AML experts. We then analysed >2500 real-world cases using the same algorithm, confirming the existence of 21/22 of these scenarios and demonstrating that our novel approach could generate a consensus AML induction treatment in 98% of cases. Our approach, driven by the use of decision trees, is an efficient way to develop consensus guidance rapidly and could be applied to other disease areas. It has the potential to be updated frequently to capture changes in eligibility criteria, novel therapies and emerging trial data. An interactive digital version of the consensus guideline is available.Citation
Coats T, Bean D, Basset A, Sirkis T, Brammeld J, Johnson S, et al. A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemia. British Journal of Haematology.7.Journal
Br J HaematolDOI
10.1111/bjh.18013PubMed ID
34957541Additional Links
https://dx.doi.org/10.1111/bjh.18013Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1111/bjh.18013
Scopus Count
Collections
Related articles
- [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
- Authors: Pituch-Noworolska A
- Issue date: 2001
- Management Approach to Acute Myeloid Leukemia Leveraging the Available Resources in View of the Latest Evidence: Consensus of the Saudi Society of Blood and Marrow Transplantation.
- Authors: Alahmari B, Alzahrani M, Al Shehry N, Tawfiq O, Alwasaidi T, Alhejazi A, Bakkar M, Al Behainy A, Radwi M, Alaskar A
- Issue date: 2021 Jul
- Acute myeloid leukaemia.
- Authors: Short NJ, Rytting ME, Cortes JE
- Issue date: 2018 Aug 18
- Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age.
- Authors: Roug AS, Hansen MC, Nederby L, Hokland P
- Issue date: 2014 Oct
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.
- Authors: Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, Dombret H, Ebert BL, Fenaux P, Larson RA, Levine RL, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz M, Sierra J, Tallman MS, Tien HF, Wei AH, Löwenberg B, Bloomfield CD
- Issue date: 2017 Jan 26